Covid-19: NVX-CoV2373 Vaccine Highly Effective in PREVENT-19 Trial
Novel vaccine showed 100% efficacy against moderate-to-severe disease The NVX-CoV2373 (Novavax)...
Read More
BreakingMed
Earlier Dx Partly Responsible for Decrease in NSCLC Death
Histologic shift to adenocarcinomas during this time also played a role From 2006 to 2016, deaths...
Read More
Apatinib Prolonged PFS, OS in Locally Advanced/Metastatic Thyroid Cancer
Treatment may represent a good alternative to other currently approved angiogenesis inhibitors...
Read More
FDA Gives Voxelotor Accelerated Approval for Kids with Sickle Cell Disease
Agency expands indication to patients as young as 4 years The FDA granted accelerated approval to...
Read More
FDA OKs First Prophylactic Drug for Graft Versus Host Disease
Abatacept/immunosuppressant therapy combo indicated for patients as young as 2 years old The FDA...
Read More
FDA Gives Nod to Upadacitinib for PsA
JAK inhibitor indicated for patients after inadequate response to TNF blockers The FDA approved...
Read More
FDA Grants Budesonide Accelerated Approval for Adults with Nephropathy
Delayed release capsules cut proteinuria in patients at risk for rapid disease progression The FDA...
Read More
Genetic Risk May Predispose Certain Smokers to COPD
Reductions in FEV1/FVC tied to levels of genetic risk Decreases in FEV1/FVC and airflow...
Read More
DLBCL: Polatuzumab Vedotin Enhances Progression-Free Survival
New regimen improves outlook in diffuse large B-cell lymphoma ATLANTA—A new regimen that...
Read More
Covid-19: ACIP Endorses mRNA Vaccines Over J&J Shot
Data suggests post-vax blood clotting is more common than previously thought The CDC’s...
Read More
Multiple Myeloma: Second-Line Therapies Continue to Evolve
Myeloma survival tracks the evolution of second-line options ATLANTA—Multiple myeloma...
Read More
Post-Stroke Epilepsy: Anti-Seizure Drugs May Be Linked to Mortality
Population-based study suggests survival may vary by treatment Mortality of patients with...
Read More
Covid-19: Updated Results Suggest Efficacy of Pfizer’s Antiviral Pill
Will the positive new data spur an FDA authorization? The latest findings from the phase II/III...
Read More
Classification System May Identify Patients Likely to Benefit from PFO Closure
System has potential to guide individual decision-making A causal classification system applied to...
Read More
Myocarditis Risk Higher with Covid-19 Infection Than Vaccination
UK population study is largest to compare infection, vaccination risk The risk for developing...
Read More
STOMP Trial Supports Selinexor in Myeloma Refractory to Anti-CD38 Monoclonal Antibodies
Selinexor combinations boost ORR and PFS ATLANTA—A truism recognized by both clinicians and...
Read More
New Combo of Ivosidenib/Azacitidine Improves Outcomes in AML
Subset of patients benefit from extended survival on dual therapy ATLANTA—A combination...
Read More
Acute Appendicitis: Looking at Treatment Options Beyond Surgery
Appendectomy still on top, but antibiotics-upfront approach is viable Surgery should be the...
Read More
Covid-19: AMA and Other Medical Orgs Continue to Push for Vax Requirements
Medical organizations file amicus briefs to urge vaccination for federal contractors The American...
Read More
Mom’s Cervical Cancer Exposure Won’t Boost HPV Shots for Their Kids
Kids only slightly more likely to get two-dose vax if mothers had a history of cervical biopsy A...
Read More